Did Pulse Biosciences, Inc. raise money recently?

Pulse Biosciences, Inc. disclosed another material event (8-K item 8.01) on 2026-07-29. The filing is on record with the SEC and is linked below. Fundz records 15 funding or SEC 8-K events for Pulse Biosciences, Inc. in the last 365 days, each linked to its source document.

What is the most recent SEC filing or funding event for Pulse Biosciences, Inc.?

Pulse Biosciences, Inc. disclosed another material event (8-K item 8.01). (2026-07-29), sourced from SEC filing at https://www.sec.gov/Archives/edgar/data/1625101/000143774926024758/0001437749-26-024758-index.htm

Signals · pulsebiosciences.com

What just happened at Pulse Biosciences, Inc.

Name: Funding and SEC 8-K events for Pulse Biosciences, Inc.
Creator: Fundz

Last updated 2026-09-08

Pulse Biosciences, Inc. disclosed another material event (8-K item 8.01) on 2026-07-29. The filing is on record with the SEC and is linked below.

The evidence, dated and sourced

2026-07-29 — SEC 8-K: Pulse Biosciences, Inc. disclosed another material event (8-K item 8.01).
SEC filing →
2026-06-10 — SEC 8-K: Pulse Biosciences, Inc. disclosed another material event (8-K item 8.01).
SEC filing →
2026-05-05 — Funding: Pulse Biosciences, Inc. disclosed another material event (8-K items 8.01).
Press / news →
2026-04-16 — SEC 8-K: Pulse Biosciences, Inc. made a Regulation FD disclosure (8-K item 7.01).
SEC filing →
2026-04-08 — SEC 8-K: Pulse Biosciences, Inc. changed directors or principal officers (8-K item 5.02).
SEC filing →
2026-04-07 — SEC 8-K: Pulse Biosciences, Inc. disclosed another material event (8-K item 8.01).
SEC filing →
2026-03-23 — SEC 8-K: Pulse Biosciences, Inc. changed directors or principal officers (8-K item 5.02).
SEC filing →
2026-03-17 — SEC 8-K: Pulse Biosciences, Inc. disclosed another material event (8-K item 8.01).
SEC filing →
2026-03-12 — SEC 8-K: Pulse Biosciences, Inc. disclosed another material event (8-K item 8.01).
SEC filing →
2026-03-06 — SEC 8-K: Pulse Biosciences, Inc. disclosed another material event (8-K item 8.01).
SEC filing →
2026-02-27 — SEC 8-K: Pulse Biosciences, Inc. changed directors or principal officers (8-K item 5.02).
SEC filing →
2026-02-05 — SEC 8-K: Pulse Biosciences, Inc. disclosed another material event (8-K item 8.01).
SEC filing →
2025-12-18 — SEC 8-K: Pulse Biosciences, Inc. completed an acquisition or disposition of assets (8-K item 2.01).
SEC filing →
2025-12-09 — SEC 8-K: Pulse Biosciences, Inc. changed directors or principal officers (8-K item 5.02).
SEC filing →
2025-12-09 — SEC 8-K: Pulse Biosciences, Inc. disclosed another material event (8-K item 8.01).
SEC filing →

How this is sourced

Every row above links to the document it came from — an SEC filing on EDGAR, or the announcement a publisher ran. Fundz does not paraphrase a source it has not stored, and each row is labelled sec_filing or press_or_news so you can see which you are reading. Funding rounds come from SEC Form D filings and announcements; 8-K events come from the filings themselves. No contact or people data appears here.

Companies with recent events

Akelos — last event 2026-03-09
HUB — last event 2026-08-06
Presto — last event 2026-01-08

Get this via API or MCP

The same evidence, as JSON, for your own agents. Quickstart → · MCP endpoint https://api.fundz.net/v1/agent/mcp

curl -s -X POST https://api.fundz.net/v1/agent/why_now \
  -H "X-Fundz-Key: $FUNDZ_KEY" -H "Content-Type: application/json" \
  -d '{"domain": "pulsebiosciences.com"}'